Prurigo nodularis
MONDO:0026045Prurigonodularis (PN) is a skin disease in which hard crusty lumps are formed on the skin that itches intensely. Repetitive rubbing, scratching, and touching results in more lesions in the skin. The itching is so intense that people scratch themselves to the point of bleeding or pain. The lumps formed in the skin are hard, and have about a half inch across, with a dry and rough top that is often scratched open. They tend to be located in the areas most easily reached and are worse on the outer sides: arms, shoulders and legs. The trunk, face and even palms can also be affected. The exact cause is unknown but some factors triggering PN include liver and kidneys problems, nervous and mental conditions and other skin diseases. Prurigo nodulares, in some cases, can be seen in other diseases such as lymphoma, chronic autoimmune cholestatic hepatitis, HIV infection, severe anemia,or a chronic kidney disease-related itching known as uremic pruritus. Treatment is very difficult, and may include corticoids, antihistaminic and other medication such as thalidomide and similar (Lenalidomide). In some cases, cryotherapy, photochemotherapy and habit reversal therapy for the itch-scratch cycle has improved the symptoms. PN can last for many years, and the itching is so intense that may affect all the everyday activities.
26 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
New drug aims to calm relentless itch of prurigo nodularis
Symptom relief Stopped earlyThis phase 3 study tests rocatinlimab, an injectable drug, against a placebo in 469 adults with prurigo nodularis—a condition causing intense itching and hard bumps on the skin. Participants had not gotten enough relief from topical treatments. The main goal is to see if the drug…
Phase 3 • Sponsor: Amgen • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
New drug offers hope for severe itch from skin lumps
Symptom relief Stopped earlyThis study tested the drug upadacitinib in 5 adults with moderate-to-severe prurigo nodularis, a condition causing very itchy skin bumps. The main goal was to see if it reduces itching by at least 4 points on a scale after 12 weeks. The study was stopped early, so results are lim…
Phase 4 • Sponsor: Psoriasis Treatment Center of Central New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC